REV Group Inc. was upgraded to equal weight from underweight by Morgan Stanley (NYSE:MS) driven by better operational execution, easing cost pressures, and strong demand in its fire and emergency ...

The clinical-stage biotechnology company announced an 85% remission rate in evaluable frontline AML patients treated with mipletamig in combination with standard-of-care venetoclax and azacitidine.

The maker of ChatGPT confirmed it is phasing out work with Scale AI, which provided only a small portion of OpenAI’s total ...

Investing.com -- Chipmaker Wolfspeed Inc. (NYSE: WOLF) is close to finalizing a deal with creditors that would place the company in bankruptcy temporarily to reduce its debt burden, according to ...